Activation of the c- myb Locus by Viral Insertional Mutagenesis in Plasmacytoid Lymphosarcomas-Reference-Cited by-同舟云学术

Activation of the c- myb Locus by Viral Insertional Mutagenesis in Plasmacytoid Lymphosarcomas

Published:1984-11-30 Issue:4678 Volume:226 Page:1077-1080
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Shen-Ong Grace L. C.¹,Potter Michael¹,Mushinski J. Frederic¹,Lavu Sukadev²,Reddy E. Premkumar²

Affiliation:

1. Laboratory of Genetics, National Cancer Institute, Bethesda, Maryland 20205

2. Laboratory of Cellular and Molecular Biology, National Cancer Institute

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference26 articles.

1. DAVIS, R.W., METHODS IN ENZYMOLOGY 21: 413 (1971).

2. DUESBERG, P.H., GENETIC-STRUCTURE OF AVIAN-MYELOBLASTOSIS VIRUS, RELEASED FROM TRANSFORMED MYELOBLASTS AS A DEFECTIVE VIRUS PARTICLE, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES 77: 5120 (1980).

3. GOFF, S.P., STRUCTURE OF THE ABELSON MURINE LEUKEMIA-VIRUS GENOME AND THE HOMOLOGOUS CELLULAR GENE - STUDIES WITH CLONED VIRAL-DNA, CELL 22: 777 (1980).

4. GONDA, T.J., THE GENOME AND THE INTRACELLULAR RNAS OF AVIAN-MYELOBLASTOSIS VIRUS, CELL 23: 279 (1981).

5. GRUNWALD, D.J., LOSS OF VIRAL GENE-EXPRESSION AND RETENTION OF TUMORIGENICITY BY ABELSON LYMPHOMA-CELLS, JOURNAL OF VIROLOGY 43: 92 (1982).

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T‐cell lymphoblastic leukemia;HemaSphere;2024-03

2. Chimeric Antigen Receptor Delivery Approaches in the Era of Regulatory-Approved T-cell Products for Cancer Immunotherapy;Trends in Medical Sciences;2023-06-03

3. Digital polymerase chain reaction strategies for accurate and precise detection of vector copy number in chimeric antigen receptor T-cell products;Cytotherapy;2023-01

4. Myb drives B-cell neoplasms and myeloid malignancies in vivo;Blood Advances;2022-05-16

5. Standardizing CAR-T therapy: Getting it scaled up;Biotechnology Advances;2019-01